Skip to main content

Laparoscopic versus open abdominoperineal resection in rectal cancer: lower successful resection and higher 3-year local recurrence: a multicenter study

In brief

Laparoscopic abdominoperineal resection had 8% 3-year recurrence versus 2% with open surgery

Among 321 patients whose rectal cancer operation ended in abdominoperineal resection, local recurrence by 3 years was 8.1% after laparoscopic surgery versus 1.9% after open surgery, and successful resection was less frequent. Laparoscopy reduced blood loss and short-term complications, with no detected survival difference; this post-hoc finding is a local-control signal, not proof of overall cancer inferiority.

Journal
Surgical endoscopy (Q1)
Published
17 November 2026
Study design
Randomized controlled trial
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Xiaojie Wang, Ying Huang, Pan Chi
PMID
43043402
DOI
10.1007/s00464-026-13443-8

Why clinicians should know about it

  • Picked for Surgical Oncology (paper of the day, 20 November 2026): Rectal resection route linked to margins and local recurrence

Abstract

BACKGROUND: Laparoscopic abdominoperineal resection (LAPR) is widely assumed non-inferior to open APR (OAPR), yet existing evidence derives from small retrospective series or randomised trials that pre-labelled patients as "definite APR" before surgery-thereby sacrificing any opportunity for intra-operative sphincter preservation and compromising patient autonomy. This post-hoc emulation of the LASRE trial compared successful resection rates and 3-year oncological outcomes between LAPR and OAPR using a "randomise-to-route, decide-at-surgery" design that preserves sphincter-saving options. METHODS: Adults with rectal cancer ≤ 5 cm from the dentate line enrolled in the multicentre LASRE RCT (22 Chinese Centres, 2013-2018) were randomised 2:1 to laparoscopic or open resection; the final decision to perform APR was made intra-operatively. The primary endpoints were successful resection (complete or near-complete total mesorectal excision plus a circumferential resection margin ≥ 1 mm) and 3-year local recurrence (LR). Sensitivity analyses comprised as-treated and conversion-excluded sets, multivariable adjustment, and formal interaction testing. RESULTS: Of 321 patients whose final operation was APR (215 LAPR, 106 OAPR), baseline characteristics were balanced except age (58 vs 57 years, P = 0.048) and clinical stage I (43.7% vs 29.3%, P = 0.012). Successful resection was achieved less frequently with LAPR (89.1% vs 96.6%, P = 0.038). Three-year LR was higher after LAPR (8.1% vs 1.9%; HR 4.445, 95% CI 1.027-19.240; P = 0.029), and this association persisted in as-treated and conversion-excluded sensitivity analyses (HR 4.66 and 4.52, respectively), whereas 3-year disease-free survival (76.3% vs 73.4%; HR 0.888, 95% CI 0.558-1.413; P = 0.616) and overall survival (89.3% vs 89.5%; HR 1.019, 95% CI 0.494-2.102; P = 0.959) did not differ. LAPR reduced blood loss (50 vs 100 mL, P < 0.001), 30-day morbidity (13.7% vs 24.5%, P = 0.017) and perineal wound infection (6.2% vs 13.2%, P = 0.034). CONCLUSION: In this post-hoc analysis, even among credentialed surgeons, LAPR was associated with short-term recovery benefits but lower successful-resection rates and a higher observed rate of 3-year local recurrence. These findings represent a local-control signal rather than definitive evidence of overall oncological inferiority, and require validation before any change in practice. TRIAL REGISTRATION: Parent trial: ClinicalTrials.gov NCT01899547.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.